Stanford University
Showing 1,761-1,780 of 2,823 Results
-
Lekha Mikkilineni
Assistant Professor of Medicine (Blood and Marrow Transplantation & Cellular Therapy)
BioDr. Lekha Mikkilineni is a board-certified medical oncologist. She is also an Assistant Professor in the Department of Medicine, Division of Blood & Marrow Transplant and Cellular Therapy.
Dr. Mikkilineni has extensive experience treating blood and bone marrow cancers. She currently provides care through the Bone Marrow Transplant & Cellular Therapy Program at Stanford Health Care. Her clinical focus is multiple myeloma, plasma-cell leukemia, Extramedullary myeloma, high-risk myeloma, CAR T cell therapy, bispecific therapy, amyloidosis, POEMS syndrome, and Waldenstrom’s macroglobunemia.
Dr. Mikkilineni’s research centers on exploring novel CAR T-cell therapies to treat multiple myeloma and to define mechanisms of resistance to immunotherapy. She is particularly focused on understanding how to improve therapies for multiple myeloma patients who have extramedullary disease or high-risk features. Prior to coming to Stanford, she ran phase 1 CAR T-cell trials for multiple myeloma targeting BCMA and SLAMF7 at the National Cancer Institute.
Dr. Mikkilineni received the Conquer Cancer Foundation Young Investigator Award from the American Society of Clinical Oncology for her research focusing on SLAMF7 as a potential target for multiple myeloma. She has received honors and awards for her work at the NCI. She has completed fellowships in hematology/oncology and immunotherapy at the National Heart, Lung, and Blood Institute/National Cancer Institute. She finished her residency in internal medicine at Thomas Jefferson University Hospital. She holds a Master of Science in medical sciences from Boston University and a medical degree from Tulane University.
Dr. Mikkilineni has authored book chapters and published research in numerous high-impact academic journals. She has presented her findings through oral and poster presentations at national and international conferences. -
David Miklos
James and Katherine Lau Professor
Current Research and Scholarly InterestsDr. Miklos is the Chief of BMT & Cell Therapy Program. He leads clinical trials treating patients with lymphoma. His correlative research studies: 1) tumor antigen quantification, 2) single cell functional product characterization, 3) CAR-FACS immune phenotyping of blood and tumor, and identifying mechanisms for CAR-T treatment Failure including antigen loss, CAR-T exhaustion, and CAR suppression.
-
Despina Milathianaki
Development Manager, SLAC National Accelerator Laboratory
BioDespina is the director of the Office of Technology Transfer and Strategic Partnerships, in the organization of the SLAC Deputy Director for Science and Technology. She and her team help accelerate the translation of cutting-edge research into transformative technologies and solutions through collaborations with industry, academia, and government partners. Before her current role, Despina served as senior director for Department of Energy partnerships in the quantum computing industry establishing important R&D efforts between the private sector and the national labs. Prior roles in the private sector included management consulting for Accenture UK and engineering for a Silicon valley startup. Despina first joined SLAC in 2010 as a staff scientist at the Linac Coherent Light Source investigating materials science at extreme conditions. She later transitioned to strategic planning where she served as the director of strategic planning and investment for SLAC. Despina holds a Bachelor's in Physics from Imperial College London and a Master’s in Electrical Engineering from the University of Michigan. She completed her PhD in High Energy Density Physics at the University of Texas at Austin, conducting research at Lawrence Livermore National Laboratory.
-
Christina Milcarek
Executive Administrator, Med/Stanford Center for Clinical Research
Current Role at StanfordProviding executive support to:
Dr. Kenneth Mahaffey, Founding Director, Stanford Center for Clinical Research (SCCR)
